Beam Therapeutics, Inc. (BEAM)
31.85
+0.27
(+0.85%)
USD |
NASDAQ |
May 13, 11:36
Beam Therapeutics Cash from Investing (Quarterly) : 25.27M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 66.31M |
| Twist Bioscience Corp. | -12.71M |
| Recursion Pharmaceuticals, Inc. | -0.338M |
| Anika Therapeutics, Inc. | -1.239M |
| BioCryst Pharmaceuticals, Inc. | -268.65M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -128.51M |
| Cash from Financing (Quarterly) | 96.61M |
| Free Cash Flow | -383.84M |
| Free Cash Flow Per Share (Quarterly) | -1.266 |
| Free Cash Flow to Equity (Quarterly) | -227.44M |
| Free Cash Flow to Firm (Quarterly) | -130.74M |
| Free Cash Flow Yield | -11.68% |